|
Name |
Koninginin E
|
Molecular Formula | C16H26O4 | |
IUPAC Name* |
(2S,8R)-8-hydroxy-2-[(1S)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydrochromen-5-one
|
|
SMILES |
CCCCCC[C@@H]([C@@H]1CCC2=C(O1)[C@@H](CCC2=O)O)O
|
|
InChI |
InChI=1S/C16H26O4/c1-2-3-4-5-6-13(18)15-10-7-11-12(17)8-9-14(19)16(11)20-15/h13-15,18-19H,2-10H2,1H3/t13-,14+,15-/m0/s1
|
|
InChIKey |
INHVGPIPHZJQOP-ZNMIVQPWSA-N
|
|
Synonyms |
Koninginin E; (2S,8R)-8-hydroxy-2-[(1S)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydrochromen-5-one; 154631-25-1; SCHEMBL20203701; DTXSID00891814; CHEBI:181853; ZINC31156404; Q63408890; NCGC00380345-01!(2S,8R)-8-hydroxy-2-[(1S)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydrochromen-5-one
|
|
CAS | 154631-25-1 | |
PubChem CID | 11426065 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 282.37 | ALogp: | 2.2 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 20 | QED Weighted: | 0.734 |
Caco-2 Permeability: | -4.655 | MDCK Permeability: | 0.00002500 |
Pgp-inhibitor: | 0.937 | Pgp-substrate: | 0.373 |
Human Intestinal Absorption (HIA): | 0.042 | 20% Bioavailability (F20%): | 0.982 |
30% Bioavailability (F30%): | 0.903 |
Blood-Brain-Barrier Penetration (BBB): | 0.359 | Plasma Protein Binding (PPB): | 73.35% |
Volume Distribution (VD): | 0.775 | Fu: | 16.76% |
CYP1A2-inhibitor: | 0.027 | CYP1A2-substrate: | 0.795 |
CYP2C19-inhibitor: | 0.035 | CYP2C19-substrate: | 0.627 |
CYP2C9-inhibitor: | 0.042 | CYP2C9-substrate: | 0.779 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.543 |
CYP3A4-inhibitor: | 0.022 | CYP3A4-substrate: | 0.108 |
Clearance (CL): | 14.647 | Half-life (T1/2): | 0.846 |
hERG Blockers: | 0.024 | Human Hepatotoxicity (H-HT): | 0.234 |
Drug-inuced Liver Injury (DILI): | 0.256 | AMES Toxicity: | 0.051 |
Rat Oral Acute Toxicity: | 0.885 | Maximum Recommended Daily Dose: | 0.603 |
Skin Sensitization: | 0.154 | Carcinogencity: | 0.714 |
Eye Corrosion: | 0.017 | Eye Irritation: | 0.197 |
Respiratory Toxicity: | 0.056 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002643 | 1.000 | D0V0IX | 0.286 | ||||
ENC005927 | 1.000 | D0I4DQ | 0.276 | ||||
ENC005887 | 0.727 | D0L7AS | 0.275 | ||||
ENC002090 | 0.676 | D0XN8C | 0.264 | ||||
ENC002691 | 0.648 | D06FEA | 0.263 | ||||
ENC003975 | 0.605 | D01WUA | 0.262 | ||||
ENC005466 | 0.562 | D00CTS | 0.238 | ||||
ENC003134 | 0.562 | D03ZJE | 0.237 | ||||
ENC003574 | 0.562 | D02AXG | 0.230 | ||||
ENC005890 | 0.541 | D0O1UZ | 0.227 |